The prognostic role of sporadic TP53 mutations in the triple-negative breast cancer group

被引：0
|
作者：
Maksimenko, E. [1 ]
Irmejs, A. [1 ]
Berzina, D. [1 ]
Nakazawa-Miklasevica, M. [2 ]
Trofimovics, G. [3 ]
Gardovkis, J. [3 ]
Miklasevics, E. [1 ]
机构：
[1] Riga Stradins Univ, Inst Oncol, Riga, Latvia
[2] Riga Stradins Univ, Inst Oncol, Mol Genet Lab, Riga, Latvia
[3] Riga Stradins Univ, Riga, Latvia
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S118 / S118
页数：1
相关论文
共 50 条
  • [31] Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer
    Liu, Jinfeng
    Zhang, Chang
    Liu, Shuang
    Wang, Xiaokang
    Wu, Xiongzhi
    Hao, Jian
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2023, 396 (02) : 365 - 374
  • [32] Tanshinone IIA promotes apoptosis by downregulating BCL2 and upregulating TP53 in triple-negative breast cancer
    Jinfeng Liu
    Chang Zhang
    Shuang Liu
    Xiaokang Wang
    Xiongzhi Wu
    Jian Hao
    Naunyn-Schmiedeberg's Archives of Pharmacology, 2023, 396 : 365 - 374
  • [33] Prognostic value genotypes and LOH at TP53 codon 72 and TP53mutations in primary breast cancer
    M Kyndi
    J Alsner
    LL Hansen
    FB Sørensen
    J Overgaard
    Breast Cancer Research, 7
  • [34] TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
    Fernandez, Sandra V.
    Bingham, Catherine
    Fittipaldi, Patricia
    Austin, Laura
    Palazzo, Juan
    Palmer, Gary
    Alpaugh, Katherine
    Cristofanilli, Massimo
    BREAST CANCER RESEARCH, 2014, 16 (05):
  • [35] TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients
    Sandra V Fernandez
    Catherine Bingham
    Patricia Fittipaldi
    Laura Austin
    Juan Palazzo
    Gary Palmer
    Katherine Alpaugh
    Massimo Cristofanilli
    Breast Cancer Research, 16
  • [36] Somatic Mutations of TP53 and Prognostic Factors for Primary Operable Breast Cancer: Correspondence
    Sookaromdee, Pathum
    Wiwanitkit, Viroj
    JOURNAL OF BREAST CANCER, 2022, 25 (06) : 522 - 522
  • [37] TP53 mutations and SNPs as prognostic and predictive factors in patients with breast cancer (Review)
    Huszno, Joanna
    Grzybowska, Ewa
    ONCOLOGY LETTERS, 2018, 16 (01) : 34 - 40
  • [38] Racial disparity in the TP53 mutation spectra in triple-negative breast cancers: Validation with TCGA data
    Putcha, Balananda-Dhurjati Kumar
    Hebert-Magee, Shantel
    Jadhav, Trafina
    Frost, Andra R.
    Eltoum, Isam-Eldin
    Manne, Upender
    CANCER RESEARCH, 2014, 74 (19)
  • [39] TP53 mutations are not prognostic independent indicators in bladder cancer
    Agnese, V.
    Corsale, S.
    Augello, C.
    Bruno, L.
    Calo, V.
    Cammareri, P.
    Cascio, S.
    Gargano, G.
    Gregorio, V.
    Gullo, A.
    La Rocca, G.
    Sisto, P. S.
    Valerio, M. R.
    Di Fede, G.
    Martorana, A.
    Bazan, V.
    Russo, A.
    ANNALS OF ONCOLOGY, 2005, 16 : 152 - 152
  • [40] Germline Mutations in Triple-Negative Breast Cancer
    Hahnen, Eric
    Hauke, Jan
    Engel, Christoph
    Neidhardt, Guido
    Rhiem, Kerstin
    Schmutzler, Rita K.
    BREAST CARE, 2017, 12 (01) : 15 - 19
12345